Trial Profile
Efficacy and safety of artemisinin-based combination therapy: artesunate-amodiaquine (ASAQ) and artemether-lumefantrine (AL) in the treatment of uncomplicated falciparum malaria in 4 provinces of Burundi
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Artemether/lumefantrine (Primary) ; Artesunate/amodiaquine (Primary)
- Indications Malaria
- Focus Therapeutic Use
- 08 Jun 2016 Status changed from not yet recruiting to completed.
- 13 Mar 2015 New trial record